The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The U.S. has detected the NB.1.8.1 COVID-19 variant, dominant in China, through airport screenings and health departments ...

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all ...

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...

Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...

The highest dividend-paying stocks in the S&P 500 right now are blue-chip stocks that yield anywhere between 6.2% and 9.3% annually. And while markets are largely flat since Jan. 1 — with a ...